Related Experiment Videos
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickens
Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1980
Summary
Congenital factor VII deficiency presents diagnostic challenges due to varied abnormalities. Differentiating these requires specialized testing with diverse tissue thromboplastins.
Area of Science:
- Hematology
- Coagulation Disorders
- Clinical Diagnostics
Background:
- Congenital factor VII deficiency, identified in 1951, is a known bleeding disorder.
- Recent decades revealed diverse factor VII abnormalities, often marked by discrepancies between clotting activity and antigen levels.
- Newer abnormalities exhibit unique sensitivities to specific thromboplastins, complicating diagnosis.
Purpose of the Study:
- To highlight the diagnostic complexities of congenital factor VII abnormalities.
- To emphasize the need for advanced diagnostic approaches in factor VII deficiencies.
- To differentiate between various factor VII clotting disorders.
Main Methods:
- Review of described congenital factor VII abnormalities.
- Analysis of discrepancies between factor VII clotting activity and cross-reacting material/antigen.
- Evaluation of thromboplastin sensitivities in factor VII variants.
Main Results:
- Several congenital factor VII abnormalities characterized by activity-antigen discrepancies have been identified.
- Some factor VII variants show specific sensitivities to ox-brain thromboplastins.
- These findings complicate the differential diagnosis of prothrombin complex factor deficiencies.
Conclusions:
- Accurate diagnosis of congenital factor VII deficiency requires a comprehensive panel of tests.
- Utilizing tissue thromboplastins from various sources is crucial for differential diagnosis.
- Advanced diagnostic strategies are essential for managing complex factor VII abnormalities.